Exxon holds a High Morningstar Uncertainty Rating based on fundamental exposure to commodity prices, evaluation of ESG risks, and the range of return outcomes used by our star rating system.

We are now looking to downsize and move to another home and I'm wondering if we should put the new property in joint names. I would not want to leave her homeless once I pass. I have two children, ...

Federal Reserve Governor Christopher Waller said Wednesday that he supported more interest rate cuts this year and didn't think that proposed import tariffs from the incoming Trump administration will ...

I'm considering downsizing to one car to save about $1,600 a year' My husband is retired and I'm semi-retired working about 20 hours a month at my own business. We have two cars but the one with the ...

Drug discovery is a key area for AI, given the speed at which models trained on massive datasets can tackle a variety of tasks. Last year, Nvidia said it was doubling down on AI-powered drug discovery ...

U.S. stock futures rose modestly and European markets made gains. Minutes from the meeting will be published at 2 p.m. Eastern on Wednesday.

STOCKHOLM--Ericsson named Anthony Bartolo as chief executive of a new company launched by a group of global telecom operators to boost development of new digital services.

Pro-cannabis businesses have accused the U.S. Drug Enforcement Administration of "an unalterably closed mind" toward lowering marijuana to a less-dangerous category level and said the federal agency ...

New jobless claims, a proxy for layoffs, fell by 10,000 to 201,000 in seven days ended Jan. 4, the government said. The report was moved up a day because of former President Jimmy Carter's funeral on ...

The stocks are falling hard on Wednesday, however, after Nvidia Corp.'s (NVDA) chief executive outlined some other realities for the quantum sector, including that quantum computers are still a ways ...

The week through Jan. 4 brought 201,000 initial jobless claims, compared with 211,000 a week earlier. Economists polled by The Wall Street Journal had been forecasting 215,000 initial claims.

Johnson & Johnson on Wednesday said it has won Food and Drug Administration fast-track designation for its proposed posdinemab treatment for Alzheimer's disease. J&J is investigating the internally ...